These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2298705)

  • 41. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.
    Georgotas A; McCue RE; Cooper TB; Nagachandran N; Friedhoff A
    Psychiatry Res; 1989 Apr; 28(1):1-9. PubMed ID: 2662234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and biological parameters as predictors for antidepressant drug responses in depressed patients.
    Fähndrich E
    Pharmacopsychiatria; 1983 Nov; 16(6):179-85. PubMed ID: 6665027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Blood MAO/DBH index and the results of the treatment of endogenous depression].
    Puzyński S; Hauptmann M; Rode A; Kalinowski A; Bidzińska E; Beresewicz M; Bidziński A
    Psychiatr Pol; 1990; 24(3):202-8. PubMed ID: 2084728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma levels of catecholamines and dihydroxyphenylglycol during antidepressant drug treatment.
    Robinson DS; Johnson GA; Nies A; Corcella J; Cooper TB; Albright D; Howard D
    J Clin Psychopharmacol; 1983 Oct; 3(5):282-7. PubMed ID: 6355207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet MAO activity in anorexia nervosa patients with and without a major depressive disorder.
    Biederman J; Rivinus TM; Herzog DB; Ferber RA; Harper GP; Orsulak PJ; Harmatz JS; Schildkraut JJ
    Am J Psychiatry; 1984 Oct; 141(10):1244-7. PubMed ID: 6486260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical symptoms and platelet monoamine oxidase in subgroups and different states of affective disorders.
    Wahlund B; Sääf J; Wetterberg L
    J Affect Disord; 1995 Oct; 35(1-2):75-87. PubMed ID: 8557890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The anticholinergic biperiden in depressive disorders.
    Kasper S; Moises HW; Beckmann H
    Pharmacopsychiatria; 1981 Nov; 14(6):195-8. PubMed ID: 7323139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet and plasma amine oxidase inhibition and urinary amine excretion changes during phenelzine treatment.
    Murphy DL; Brand E; Goldman T; Baker M; Wright C; van Kammen D; Gordon E
    J Nerv Ment Dis; 1977 Feb; 164(2):129-34. PubMed ID: 836485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Response to phenelzine among depressed patients with features of hysteroid dysphoria.
    Kayser A; Robinson DS; Nies A; Howard D
    Am J Psychiatry; 1985 Apr; 142(4):486-8. PubMed ID: 3883817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response.
    Swann AC; Bowden CL; Rush AJ; Rhoades H; Rose R; Kobes R
    J Clin Psychopharmacol; 1997 Apr; 17(2):78-83. PubMed ID: 10950467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acetylator status and inhibition of platelet monoamine oxidase following treatment with phenelzine.
    Yates CM; Loudon JB
    Psychol Med; 1979 Nov; 9(4):777-9. PubMed ID: 515276
    [No Abstract]   [Full Text] [Related]  

  • 52. Platelet MAO activity in geriatric patients with depression and dementia.
    Alexopoulos GS; Young RC; Lieberman KW; Shamoian CA
    Am J Psychiatry; 1987 Nov; 144(11):1480-3. PubMed ID: 3674232
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of phenelzine in geriatric depression.
    Lazarus LW; Groves L; Gierl B; Pandey G; Javaid JI; Lesser J; Ha YS; Davis J
    Biol Psychiatry; 1986 Jun; 21(7):699-701. PubMed ID: 3708040
    [No Abstract]   [Full Text] [Related]  

  • 54. Electrocardiographic effects of nortriptyline, phenelzine, and placebo under optimal treatment conditions.
    Georgotas A; McCue RE; Friedman E; Cooper TB
    Am J Psychiatry; 1987 Jun; 144(6):798-801. PubMed ID: 3592003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Personality traits and monoamine oxidase activity in platelets in depressed patients.
    Perris C; Eisemann M; von Knorring L; Oreland L; Perris H
    Neuropsychobiology; 1984; 12(4):201-5. PubMed ID: 6535064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenelzine vs placebo in 50 patients with bulimia.
    Walsh BT; Gladis M; Roose SP; Stewart JW; Stetner F; Glassman AH
    Arch Gen Psychiatry; 1988 May; 45(5):471-5. PubMed ID: 3282482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liquid chromatographic determination of inhibition of monoamine oxidase activity in platelet rich plasma of depressed patients treated with phenelzine.
    Gupta RN; Steiner M
    Clin Chim Acta; 1985 Oct; 152(1-2):63-9. PubMed ID: 4053406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First results on the effects of MAO inhibition on cognitive functioning in elderly depressed patients.
    Georgotas A; Reisberg B; Ferris S
    Arch Gerontol Geriatr; 1983 Nov; 2(3):249-54. PubMed ID: 6651397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelet monoamine oxidase activity in elderly depressed outpatients.
    Schneider LS; Severson JA; Pollock V; Cowan RP; Sloane RB
    Biol Psychiatry; 1986 Dec; 21(14):1360-4. PubMed ID: 3790624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Platelet MAO deamination of serotonin in depressed patients. Changes after imipramine treatment and clinical correlations.
    Quintana J
    Biol Psychiatry; 1988 Jan; 23(1):44-52. PubMed ID: 3337854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.